Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease

American Journal of Pathology

Volumn 170, Issue 3, 2007, Pages 1064-1076

  Sadlonova, Andrea ^a   Mukherjee, Shibani ^a   Bowe, Damon B ^b   Gault, Sandra R ^a   Dumas, Nicole A ^c   Van Tine, Brian A ^a   Frolova, Natalya ^a   Page, Grier P ^d   Welch, Danny R ^a   Novak, Lea ^a   Frost, Andra R ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROPAMIDE IODIDE;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; NORMAL BREAST ASSOCIATED FIBROBLAST; PRIORITY JOURNAL; XENOGRAFT; ANIMAL; APOPTOSIS; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DISEASE MODEL; EPITHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PRECANCER;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; PRECANCEROUS CONDITIONS; TRANSPLANTATION, HETEROLOGOUS;

EID: 34247886174     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060031     Document Type: Article

References (46)

1. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C: Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002, 32:355-357
2. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH, Eng C: Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. Hum Mol Genet 2001, 10:1907-1913
3. Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature 2001, 411:375-379
4. Mueller MM, Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4:839-849
5. Bhowmick NA, Neilson EG, Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337
6. Horgan K, Jones DL, Mansel RE: Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg 1987, 74:227-229
7. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348
8. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA: Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 2000, 60:2562-2566
9. Kunz-Schughart LA, Knuechel R: Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol 2002, 17:623-637
10. Kunz-Schughart LA, Knuechel R: Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol 2002, 17:599-621
11. Tlsty TD: Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001, 11:97-104
12. Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR: Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Res 2005, 7:R46-R59
13. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 1991, 51:4978-4985
14. Heffelfinger SC, Miller MA, Yassin R, Gear R: Angiogenic growth factors in preinvasive breast disease. Clin Cancer Res 1999, 5:2867-2876
15. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y: Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 1995, 71:1039-1045
16. Brummer O, Athar S, Riethdorf L, Loning T, Herbst H: Matrix- metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch 1999, 435:566-573
17. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50:6075-6086
18. Heppner GH, Wolman SR: MCF-10AT: a model for human breast cancer development. Breast J 1999, 5:122-129
19. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR: MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996, 148:313-319
20. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH: Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 1993, 85:1725-1732
21. Shekhar MP, Werdell J, Santner SJ, Pauley RJ, Tait L: Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 2001, 61:1320-1326
22. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992, 84:1875-1887
23. Frost AR, Sparks D, Grizzle WE: Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl Immunohistochem Mol Morphol 2000, 8:236-243
24. Talley LI, Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR: Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 2002, 98:118-127
25. Kubitz R, Warskulat U, Schmitt M, Haussinger D: Dexamethasone-and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. Biochem J 1999, 340:585-591
26. Cowin P, Rowlands TM, Hatsell SJ: Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005, 17:499-508
27. Ceredig R, Rolink T: A positive look at double-negative thymocytes. Nat Rev Immunol 2002, 2:888-897
28. Hardy B, Morgenstern S, Raiter A, Rodionov G, Fadaeev L, Niv Y: BAT monoclonal antibody immunotherapy of human metastatic colorectal carcinoma in mice. Cancer Lett 2005, 229:217-222
29. Garcia-Ojeda ME, Dejbakhsh-Jones S, Chatterjea-Matthes D, Mukhopadhyay A, BitMansour A, Weissman IL, Brown JM, Strober S: Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. J Immunol 2005, 175:4363-4373
30. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, Richardson A, Weinberg RA: Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004, 101:4966-4971
31. Gache C, Berthois Y, Martin PM, Saez S: Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture. In Vitro Cell Dev Biol Anim 1998, 34:347-351
32. van Roozendaal CE, van Ooijen B, Klijn JG, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA: Stromal influences on breast cancer cell growth. Br J Cancer 1992, 65:77-81
33. van Roozendaal KE, Klijn JG, van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA: Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 1996, 65:120-125
34. Brouty-Boyé D, Mainguene C, Magnien V, Israel L, Beaupain R: Fibroblast-mediated differentiation in human breast carcinoma cells (MCF-7) grown as nodules in vitro. Int J Cancer 1994, 56:731-735
35. Gache C, Berthois Y, Cvitkovic E, Martin PM, Saez S: Differential regulation of normal and tumoral breast epithelial cell growth by fibroblasts and 1,25-dihydroxyvitamin D3. Breast Cancer Res Treat 1999, 55:29-39
36. Ryan MC, Orr DJ, Horgan K: Fibroblast stimulation of breast cancer cell growth in a serum-free system. Br J Cancer 1993, 67:1268-1273
37. Gallagher WM, Currid CA, Whelan LC: Fibulins and cancer: friend or foe? Trends Mol Med 2005, 11:336-340
38. Coronella-Wood JA, Hersh EM: Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother 2003, 52:715-738
39. Forti S, Scanlan MJ, Invernizzi A, Castiglioni F, Pupa S, Agresti R, Fontanelli R, Morelli D, Old LJ, Pupa SM, Menard S: Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res Treat 2002, 73:245-256
40. Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, Agresti R, Aiello P, Invernizzi A, Baldassari P, Twal WO, Mortarini R, Anichini A, Menard S: Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene 2004, 23:2153-2160
41. Dranoff G: Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004, 4:11-22
42. Zou W: Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005, 5:263-274
43. Quan N, Zhang Z, Demetrikopoulos MK, Kitson RP, Chambers WH, Goldfarb RH, Weiss JM: Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat. Cancer Res 1999, 59:1080-1089
44. de Visser KE, Korets LV, Coussens LM: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005, 7:411-423
45. Brouty-Boyé D, Pottin-Clemenceau C, Doucet C, Jasmin C, Azzarone B: Chemokines and CD40 expression in human fibroblasts. Eur J Immunol 2000, 30:914-919
46. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA: The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004, 108:173-180